Tech Company Financing Transactions

Semprus BioSciences Funding Round

On 12/13/2010, Semprus BioSciences landed $18 million in Series B funding from Flare Capital Partners, SR One Capital Management and 5AM Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

One Kendall Street Building 1400 1st Floor
Cambridge, MA 02139
USA

Phone

617-577-7755

Website

www.semprusbio.com

Email Address

[email protected]

Overview

Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Scott Rocklage

        

Chief Executive Officer

David Lucchino

        

Chief Technical Officer

Chris Loose

        

VP - Bus. Development

David McClellan

        

VP - Manufacturing

Douglas Weaver

        

VP - Product Management

Laurence Roth

        

Browse more venture capital transactions:

Prev: 12/13/2010: Mochila venture capital transaction
Next: 12/13/2010: Media6Degrees venture capital transaction

Share this article

Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary